These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8184803)

  • 21. Failure of epoprostenol (prostacyclin, PGI2) to inhibit platelet aggregation and to prevent restenosis after coronary angioplasty: results of a randomised placebo controlled trial.
    Gershlick AH; Spriggins D; Davies SW; Syndercombe Court YD; Timmins J; Timmis AD; Rothman MT; Layton C; Balcon R
    Br Heart J; 1994 Jan; 71(1):7-15. PubMed ID: 8297699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of beta-adrenergic blockers after percutaneous transluminal coronary angioplasty.
    Johansson SR; Lamm C; Bondjers G; Emanuelsson H; Hjalmarson A
    Am J Cardiol; 1990 Oct; 66(12):915-20. PubMed ID: 1977297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
    Jørgensen B; Thaulow E;
    Am Heart J; 2003 Jun; 145(6):1030-5. PubMed ID: 12796759
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of subcutaneous low molecular weight heparin (ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty.
    Gimple LW; Herrmann HC; Winniford M; Mammen E
    Am J Cardiol; 1999 Jun; 83(11):1524-9. PubMed ID: 10363865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of residual plaque burden after balloon angioplasty in the MultiVitamins and Probucol (MVP) trial.
    Tardif JC; Côté G; Lespérance J; Gosselin G; Joyal M; de Guise P; Bilodeau L; Doucet S; Harel F; Couturier A; Gallo R; Grégoire J
    Can J Cardiol; 2001 Jan; 17(1):49-55. PubMed ID: 11173314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of the methodology of percutaneous transluminal coronary angioplasty on restenosis.
    Douglas JS; King SB; Roubin GS
    Am J Cardiol; 1987 Jul; 60(3):29B-33B. PubMed ID: 2956837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of restenosis after coronary angioplasty: a pharmacological approach.
    Meier B
    Eur Heart J; 1989 Dec; 10 Suppl G():64-8. PubMed ID: 2697565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous regression of restenosis: an angiographic study.
    Mehta VY; Jorgensen MB; Raizner AE; Wolde-Tsadik G; Mahrer PR; Mansukhani P
    J Am Coll Cardiol; 1995 Sep; 26(3):696-702. PubMed ID: 7642861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary restenosis after optimal (stent-like) initial angiographic results obtained by traditional balloon angioplasty.
    Di Luzio V; De Remigis F; De Curtis G; Paparoni S; Pecce P; Di Emidio L; Prosperi F; D'Aroma A; Balducelli M; Maresta A
    G Ital Cardiol; 1997 Jul; 27(7):645-53. PubMed ID: 9282284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiographic predictors of recurrence of restenosis after Wiktor stent implantation in native coronary arteries.
    de Jaegere P; Serruys PW; Bertrand M; Wiegand V; Marquis JF; Vrolicx M; Piessens J; Valeix B; Kober G; Bonnier H
    Am J Cardiol; 1993 Jul; 72(2):165-70. PubMed ID: 8328378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient, lesion, and procedural variables as risk factors for luminal re-narrowing after successful coronary angioplasty: a quantitative analysis in 653 patients with 778 lesions. Multicenter European Research Trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.
    Hermans WR; Rensing BJ; Foley DP; Tijssen JG; Rutsch W; Emanuelsson H; Danchin N; Wijns W; Chappuis F; Serruys PW
    J Cardiovasc Pharmacol; 1993; 22 Suppl 4():S45-57. PubMed ID: 7523772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty. The Lovastatin Restenosis Trial Study Group.
    Weintraub WS; Boccuzzi SJ; Brown CL; Cohen CL; Hirsch LJ; King SB; Alexander RW
    Am J Cardiol; 1992 Aug; 70(3):293-9. PubMed ID: 1632391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No effect of highly dosed nitric oxide donor molsidomine on the angiographic restenosis rate after percutaneous coronary angioplasty: a randomized, placebo controlled, double-blind trial.
    Wöhrle J; Höher M; Nusser T; Hombach V; Kochs M
    Can J Cardiol; 2003 Apr; 19(5):495-500. PubMed ID: 12717484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of calcium channel blockers in reducing acute ischaemia and preventing restenosis in PTCA.
    Vahanian A; Lung B
    Drugs; 1996; 52 Suppl 4():9-15; discussion 15-6. PubMed ID: 8913714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and angiographic outcome in patients with in-stent restenosis and repeat target lesion revascularisation in small coronary arteries.
    Gross CM; Krämer J; Weingärtner O; Uhlich F; Dietz R; Waigand J
    Heart; 2000 Sep; 84(3):307-13. PubMed ID: 10956297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids.
    Dehmer GJ; Popma JJ; van den Berg EK; Eichhorn EJ; Prewitt JB; Campbell WB; Jennings L; Willerson JT; Schmitz JM
    N Engl J Med; 1988 Sep; 319(12):733-40. PubMed ID: 2842680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental and early clinical experience with reviparin-sodium for prevention of restenosis after percutaneous transluminal coronary angioplasty.
    Preisack MB; Karsch KR
    Blood Coagul Fibrinolysis; 1993 Dec; 4 Suppl 1():S55-8; discussion S59-60. PubMed ID: 8180331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracoronary stent insertion after balloon angioplasty of chronic total occlusions.
    Goldberg SL; Colombo A; Maiello L; Borrione M; Finci L; Almagor Y
    J Am Coll Cardiol; 1995 Sep; 26(3):713-9. PubMed ID: 7642864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.